DynPort Vaccine Company LLC
60 Thomas Johnson Drive
Frederick
Maryland
21702
United States
Tel: 301-607-5000
Fax: 301-607-5099
Website: http://www.dyncorp.com/
8 articles about DynPort Vaccine Company LLC
-
Altimmune Signs Teaming Agreement with DynPort Vaccine Company on U.S. Government Funding Efforts for its COVID-19 Vaccine Candidate, AdCOVID™
7/9/2020
Altimmune, Inc. announced that it has entered into a teaming agreement with DynPort Vaccine Company, a General Dynamics Information Technology company, to coordinate U.S. Government funding efforts and, if successful, to provide program management, drug development activity integration, and regulatory support for AdCOVID, Altimmune’s single-dose intranasal COVID-19 vaccine candidate.
-
CSRA's DynPort Vaccine Company LLC To Help Advance Medical Products For The NIAID
12/27/2016
-
AIBioTech Receives Subcontract Award From DynPort Vaccine Company LLC, for Continued Development and FDA Approval of a Nerve Agent Prophylactic
5/23/2013
-
CSC's DynPort Vaccine Company LLC Wins $32.3 Million NIAID Contract to Establish Phase 1 Clinical Trial
7/14/2008
-
DynPort Vaccine Company LLC to Continue Plague Vaccine Development
6/5/2008
-
ImmuneRegen BioSciences, Inc. to Provide Adjuvant to DynPort Vaccine Company LLC for Development of an Inactivated Vaccine against Venezuelan Equine Encephalitis Virus
4/30/2008
-
CSC's DVC And Baxter Begin Phase 1 Clinical Trial For Chemical Defense Product
1/18/2007
-
Covalent Group Awarded $1.1 Million Contract To Study Counter-Bioterrorism Vaccine
1/8/2004